Find a Physician

Email this profile
Portrait View Larger

John W. Day, MD, PhD

Academic Appointments

  • Professor of Neurology, of Pediatrics and, by courtesy, of Pathology at the Stanford University Medical Center

Contact Information

  • Clinical Offices
    Department of Neurology 300 Pasteur Dr Rm A342 MC 5235 Stanford, CA 94305
    Tel Work (650) 725-7622 Fax (650) 725-4197
    211 Quarry Rd Ste 206 Hoover Bldg MC 5992 Palo Alto, CA 94304
    Tel Work (650) 498-7551 Fax (650) 725-4197
  • Academic Offices
    Personal Information
    Email Tel (650) 725-7622
    Alternate Contact
    Angelica Martinez Administrative Assistant Tel Work 650-725-4341
    Not for medical emergencies or patient use

Professional Overview

Clinical Focus

  • Neurology

Academic Appointments

Administrative Appointments

  • Director, Neuromuscular Division and Clinics, Stanford University (2011 - present)
  • Director, Paul and Sheila Wellstone Muscular Dystrophy Center, U of MN (2003 - 2011)
  • Institute of Human Genetics, Executive Board, University of Minnesota (1999 - 2011)
  • Associate Head for Clinical Affairs, Neurology Department, U of MN (1999 - 2001)
  • Medical Director, Clinical, Neuroscience Research Unit (1997 - 2003)
  • Director, Center for Muscle Disorders, University of Minnesota (1996 - 2003)

Honors and Awards

  • Recognized among Best Physicians in Minnesota, Twin Cities Magazine (2010)
  • All University Post-Baccalaureate Teaching Award, University of Minnesota (2007)
  • All University Post-Baccalaureate Teaching Award, All University Post-Baccalaureate Teaching Award (2007)
  • Distinguished Teaching Award, University of Minnesota Medical School (2005)
  • Outstanding Teaching Award, University of Minnesota Medical School (2005)
  • Distinguished Teaching Award, University of Minnesota Medical School (2003)
View All 12honors and awards of John Day

Professional Education

Board Certification: Neuromuscular Disease, American Board of Psychiatry and Neurology (2011)
Internship: Montefiore Medical Center - Albert Einstein College of Medicine NY (1983)
Professional Education: Albert Einstein College of Medicine NY (1982)
Medical Education: University of Minnesota School of Medicine MN (1977)
Fellowship: UCSF CA (1987)
Board Certification: Neurology, American Board of Psychiatry and Neurology (1988)
View All 10



Scientific Focus

Current Research and Scholarly Interests

Our Neuromuscular Division organizes a comprehensive effort to combat and conquer diseases of the peripheral nerves and muscles, including the muscular dystrophies (myotonic, Duchenne, limb girdle, facioscapulohumeral, and congenital muscular dystrophies), motor neuron disorders (ALS and SMA), neuromuscular junction disease (MG, CMS), and peripheral neuropathies (CMT, CIDP). While keeping the patients and families foremost in mind, our research seeks to: define and understand genetic causes; clarify the molecular and cellular consequences of genetic change; determine the multisystemic features that are underappreciated but clinically significant consequence of these diseases; develop and improve methods for managing and treating each disease.

We have identified the genetic cause of several neuromuscular disorders, most notably myotonic dystrophy type 2, which we continue to study to advance understanding of all forms of myotonic dystrophy. We have also contributed to genetic understanding of Duchenne muscular dystrophy, and other muscle and ataxic disorders. We are continuing to investigate the epigenetic and molecular consequences of these diseases through investigation of patient-derived specimens.

We have focused on defining the central nervous system features of neuromuscular disorders, which severely impact patients and families but have been incompletely investigated, explained or managed. Detailed neuropsychological and brain MRI studies are helping to define the developmental and progressive CNS aspects of these conditions, for which we then seek molecular and cellular explanations through cell-based studies of patient-derived specimens.

To assure our research is translatable to clinical practice, we are simultaneously involved in collaborative clinical research on novel treatments for neuromuscular disease, including antisense oligonucleotides and pharmacologic manipulation of muscle function, viral gene therapies and cell-based treatments.

In summary, we work with patients to define neuromuscular disorders more rigorously and understand them more thoroughly, so novel treatments will successfully combat these devastating disorders.


Publication tag cloud

Publication Topics

View All 57

Stanford Medicine Resources:

Footer Links: